One Stop Solution For In-Depth Market Research Reports

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Cerebrospinal Fluid (CSF) Management Market

Cerebrospinal Fluid (CSF) Management Market by Product (Shunts (Ventriculoperitoneal, Ventriculoatrial, Adjustable Valve), External Drainage Systems (EVD, Lumbar Drainage)), End User (Pediatric, Adult, Geriatric) - Global Forecast to 2022


Product Code : MNMHC00109775
Survey : MarketsandMarkets
Publish On : 20, May, 2022
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

“The cerebrospinal fluid (CSF) management market is projected to grow at a CAGR of 4.4%.”
The global cerebrospinal fluid (CSF) management market is projected to reach USD 1.56 billion by 2022 from an estimated USD 1.26 billion in 2017, at a CAGR of 4.4%. The high prevalence of hydrocephalus and the subsequent increase in the number of shunting procedures and the growing geriatric population are factors driving the growth of this market. The growing healthcare market in developing economies is also expected to provide growth opportunities for players in the market. However, the dearth of trained professionals and complications related to CSF shunts may challenge market growth during the forecast period to a certain extent.

“By product, the shunts segment is expected to grow at the highest CAGR during the forecast period (2017–2022).”
The market is segmented by product into shunts and external drainage systems. The shunts segment is expected to grow at highest CAGR during the forecast period. This can be attributed to growing number of shunting procedures performed worldwide as well as the increasing number of revision shunt surgeries being performed due to shunt malfunction and infection.

“By end user, the pediatric segment is expected to be the fastest growing segment during the forecast period.”
Based on end user, the global cerebrospinal fluid (CSF) management market is segmented into pediatric, adult, and geriatric end users. The pediatric segment is expected to grow at the highest CAGR during the forecast period and this growth is attributed to the high prevalence of congenital hydrocephalus along with the rising number of shunting procedures performed in the pediatric population.

“Asia Pacific to witness the highest growth during the forecast period”
Asia Pacific is expected to grow at the highest CAGR during the study period. The highest growth rate of the Asia Pacific market can be primarily attributed to high prevalence of congenital hydrocephalus in China, growing geriatric population in Japan, and increasing medical tourism in India and several RoAPAC countries.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–65%, Tier 2–25% and Tier 3–10%
• By Designation – C-level–30%, Director Level–48%, Others–22%
• By Region – North America–48%, Europe–20%, Asia Pacific–25%, Row–7%

The key players in the global cerebrospinal fluid (CSF) management market are Medtronic (Ireland), Integra (US), B. Braun (Germany), DePuy Synthes (US), Spiegelberg GmbH & Co. KG (Germany), SOPHYSA (France), Natus Medical (US), Dispomedica GmbH (Germany), Delta Surgical Limited (UK), Argi Grup (Turkey), Moller Medical GmbH (Germany), G. SURGIWEAR LTD. (India), and Wellong Instruments Co., Ltd. (Taiwan).
Research Coverage:
The report analyzes the cerebrospinal fluid (CSF) management market and aims at estimating the market size and future growth potential of this market based on various segments such as product, end user, and region. The report also includes the competitive analysis of key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one or any combination of the below mentioned five strategies.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the cerebrospinal fluid (CSF) management market. The report analyzes the market based on product, end user, and region
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the cerebrospinal fluid (CSF) management market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various cerebrospinal fluid (CSF) management devices across regions
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the cerebrospinal fluid (CSF) management market
 

TABLE OF CONTENTS

1 INTRODUCTION 12
1.1 OBJECTIVES OF THE STUDY 12
1.2 MARKET DEFINITION 12
1.3 MARKET SCOPE 13
1.3.1 MARKETS COVERED 13
1.3.2 YEARS CONSIDERED FOR THE STUDY 14
1.4 CURRENCY 14
1.5 LIMITATIONS 14
1.6 STAKEHOLDERS 14
2 RESEARCH METHODOLOGY 15
2.1 RESEARCH DESIGN 15
2.2 RESEARCH APPROACH 16
2.2.1 SECONDARY RESEARCH 17
2.2.1.1 Secondary sources 17
2.2.2 PRIMARY RESEARCH 18
2.2.2.1 Primary sources 19
2.3 MARKET SIZE ESTIMATION METHODOLOGY 20
2.4 MARKET DATA VALIDATION AND TRIANGULATION 22
2.5 ASSUMPTIONS FOR THE STUDY 23
3 EXECUTIVE SUMMARY 24
4 PREMIUM INSIGHTS 29
4.1 GLOBAL CEREBROSPINAL FLUID (CSF) MANAGEMENT MARKET: MARKET OVERVIEW 29
4.2 CEREBROSPINAL FLUID (CSF) MANAGEMENT MARKET, BY END USER AND REGION 30
4.3 GEOGRAPHIC SNAPSHOT: CEREBROSPINAL FLUID (CSF) MANAGEMENT MARKET 31
4.4 CEREBROSPINAL FLUID (CSF) MANAGEMENT MARKET, BY PRODUCT 32
5 MARKET OVERVIEW 33
5.1 INTRODUCTION 33
5.1.1 DRIVERS 34
5.1.1.1 High prevalence of hydrocephalus and the subsequent increase in the number of shunting procedures 34
5.1.1.2 Growing geriatric population 35
5.1.2 OPPORTUNITIES 35
5.1.2.1 Growing healthcare market in developing economies 35
5.1.3 CHALLENGES 36
5.1.3.1 Dearth of trained professionals 36
5.1.3.2 Complications related to CSF shunts 36
6 CEREBROSPINAL FLUID (CSF) MANAGEMENT MARKET, BY PRODUCT 38
6.1 INTRODUCTION 39
6.2 SHUNTS 40
6.2.1 SHUNTS MARKET, BY TYPE 40
6.2.1.1 Ventriculoperitoneal (VP) shunts 41
6.2.1.2 Ventriculoatrial (VA) shunts 42
6.2.1.3 Lumboperitoneal (LP) shunts 42
6.2.1.4 Ventriculopleural (VPL) shunts 43
6.2.2 SHUNTS MARKET, BY VALVE TYPE 43
6.2.2.1 Fixed valve shunts 44
6.2.2.2 Adjustable valve shunts 44
6.3 EXTERNAL DRAINAGE SYSTEMS 45
6.3.1 EXTERNAL VENTRICULAR DRAINAGE (EVD) SYSTEMS 46
6.3.2 LUMBAR DRAINAGE (LD) SYSTEMS 47
7 CEREBROSPINAL FLUID MANAGEMENT MARKET, BY END USER 48
7.1 INTRODUCTION 49
7.2 PEDIATRIC END USERS 50
7.3 ADULT END USERS 51
7.4 GERIATRIC END USERS 52
8 CEREBROSPINAL FLUID MANAGEMENT MARKET, BY REGION 53
8.1 INTRODUCTION 54
8.2 NORTH AMERICA 55
8.2.1 US 58
8.2.2 CANADA 61
8.3 EUROPE 64
8.3.1 EU5 67
8.3.2 ROE 70
8.4 ASIA PACIFIC 73
8.4.1 JAPAN 76
8.4.2 CHINA 78
8.4.3 INDIA 81
8.4.4 REST OF ASIA PACIFIC 83
8.5 REST OF THE WORLD 86

9 MARKET SHARE ANALYSIS 90
9.1 INTRODUCTION 90
9.1.1 MEDTRONIC 90
9.1.2 DEPUY SYNTHES 91
9.1.3 B.BRAUN 91
9.1.4 INTEGRA 91
9.1.5 OTHER PLAYERS 91
10 COMPANY PROFILES 92
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
10.1 MEDTRONIC 92
10.2 INTEGRA LIFESCIENCES HOLDINGS CORPORATION 95
10.3 B. BRAUN MELSUNGEN 99
10.4 SPIEGELBERG GMBH & CO. KG 102
10.5 SOPHYSA (A SUBSIDIARY OF TKB GROUP) 103
10.6 NATUS MEDICAL INCORPORATED 104
10.7 DISPOMEDICA GMBH 106
10.8 DELTASURGICAL 107
10.9 ARGI GRUP 108
10.10 MOLLER MEDICAL GMBH 109
10.11 G. SURGIWEAR LTD 110
10.12 WELLONG INSTRUMENTS CO., LTD 111

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
11 APPENDIX 112
11.1 DISCUSSION GUIDE 112
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 116
11.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 118
11.3.1 FEATURES AND BENEFITS OF RT: 118
11.4 AVAILABLE CUSTOMIZATIONS 119
11.5 RELATED REPORTS 119
11.6 AUTHOR DETAILS 120

Shibuya data count

Shibuya Data Count is a reseller offering a variety of market research reports from different industries, provided by a global team of experienced research professionals who ensure the most reliable and up-to-date research analysis reports.

Recommended reports

+